Blog

National Infertility Awareness Week

National Infertility Awareness Week

National Infertility Awareness Week (NIAW) starts today and will be observed for a week-long until April 29th 2023.

The NIAW helps raise awareness about infertility and promote education on this common issue affecting up to 15% of couples in the United States. Infertility is defined as the inability to conceive a child after one year of trying despite regular, unprotected sexual intercourse. Both men and women can experience infertility, and many factors can contribute to the condition. For female, causes range from hormonal imbalance, ovulation disorder, blocked fallopian tube to autoimmune conditions while in male, infertility may be caused by a low sperm count or poor sperm quality sometimes due to the presence of varicoceles.

Erasing the stigma often associated with infertility may help couples who are struggling to speak out, share their journeys, hopes and heartaches and seek the help they need.

The American Society for Reproductive Medicine (ASRM) recommends pursuing a fertility evaluation with a reproductive endocrinologist if you:

  • Have been trying to naturally conceive for twelve months or more and are under 35 years old (female)
  • Have been trying to naturally conceive for six months or more and are 35 years or older (female)
  • Are a female over the age of 40 (immediate evaluation)
  • If you have irregular menstrual cycles, autoimmune issues, genetic conditions, or endometriosis, you may seek immediate evaluation regardless of your age.

To have access to all the resources NIAW has to offer, consult their website.

To learn more about when to seek help, what to expect, and what you can do if your doctor can’t find a solution, read our blog “The Infertility Patient’s Journey”.

Back to blog
We love questions

Talk to an expert

Pregmune’s fertility services experts are available to help you get started and to answer any questions you may have along the way.

Medical Disclaimer

Patients and physicians should always consult with a licensed medical professional before making any clinical decisions, including starting or discontinuing any treatment. Any information provided by Pregmune, including but not limited to the IRMA Report, AIMY Report, test results, risk estimates, supporting documentation, email communications or other related content (collectively, "Pregmune Content"), is intended for informational purposes only. This content is not medical advice and should not be used as a substitute for professional medical evaluation, diagnosis, or treatment. Pregmune Content is not a recommendation for any specific treatment plan, therapy, medication, or course of action. It is designed to support, not replace, the relationship between patients and their qualified healthcare providers. Pregmune does not provide medical care, and its reports and communications should never delay or override clinical judgment.